Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Observational Studies in Cancer Associated Thrombosis for Rivaroxaban - United States Cohort

NCT04979780 is registered in ClinicalTrials.gov with Bayer as lead sponsor.

NCT NCT04979780
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04979780 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Observational Studies in Cancer Associated Thrombosis for Rivaroxaban - United States Cohort
Lead sponsor
Bayer
Phase
Observational
Overall status
Completed
Start date
July 20, 2021
Completion date
March 31, 2022
Enrollment
3,708 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prophylaxis of recurrent venous thromboembolism in cancer patients, treatment of venous thromboembolism in cancer patients